| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 112,127 | 113,067 | 85,604 | 76,529 | | Cost of Revenue | 57,823 | 63,778 | 42,946 | 39,211 | | | Gross Profit | 54,304 | 49,289 | 42,658 | 37,318 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 56,803 | 58,845 | 44,263 | 37,105 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (2,499) | (9,556) | (1,605) | 213 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,233 | 5,644 | (1,318) | 551 | | Earnings Before Interest And Taxes | 2,734 | (3,912) | (2,923) | 764 | | Interest Expense | 139 | 335 |
-
|
-
| | Income Before Tax | 2,595 | (4,247) | (2,923) | 764 | | Income Tax Expense | 396 | 21,396 | (1,486) | 869 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,199 | (25,643) | (1,437) | (105) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,199 | (25,643) | (1,437) | (105) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,199 | ($25,643) | ($1,437) | ($105) |
|
1.23% Nasdaq 
Income Statement
